CHM 0.00% 1.0¢ chimeric therapeutics limited

Ann: New data for Phase 1A CLTX CAR T brain cancer clinical trial, page-75

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 797 Posts.
    lightbulb Created with Sketch. 533
    https://www.miragenews.com/car-t-cell-therapy-shows-promise-in-aggressive-1189756/
    https://www.nature.com/articles/s41591-024-02875-1?utm_source=miragenews&utm_medium=miragenews&utm_campaign=news

    Results from another phase 1 study from the the city of hope and our very own Christine Brown.

    Looks like their response rate and overall survival rate was very similar to our early phase 1a data.

    I dare say when we find the dose sweet spot and start dosing patients in the 2nd line of treatment, as opposed to the later lines, we'll improve upon both response and survival.

    Important to remember also "Chlorotoxin in the hands of city of hope has bound to the glioblastomas of more patients and more cells within those patients than any other agent they've tried."
 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
(20min delay)
Last
1.0¢
Change
0.000(0.00%)
Mkt cap ! $9.951M
Open High Low Value Volume
1.1¢ 1.2¢ 1.0¢ $38.54K 3.639M

Buyers (Bids)

No. Vol. Price($)
9 2646760 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.1¢ 729690 4
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.